Plasma endothelin levels and vascular responses at different temporal stages of streptozotocin diabetes

European Journal of Pharmacology

Volumn 374, Issue 2, 1999, Pages 221-227

  Hopfner, Rob L ^a   McNeill, J Robert ^a   Gopalakrishnan, Venkat ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Aorta; Endothelial derived relaxing factor; Endothelin 1; Streptozotocin diabetic, rat; Vascular responsiveness

Indexed keywords

ACETYLCHOLINE; ENDOTHELIN 1; ENDOTHELIUM DERIVED RELAXING FACTOR; METHOXAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; EXTRACELLULAR CALCIUM; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; DIABETES MELLITUS, EXPERIMENTAL; DRUG INTERACTIONS; ENDOTHELIN-1; ISOMETRIC CONTRACTION; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITROPRUSSIDE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 0033041049     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00316-7     Document Type: Article

References (35)

1. Abebe W., Macleod K.M. Protein kinase C mediated contractile responses of arteries from diabetic rats. Br. J. Pharmacol. 101:1990;465-471.
2. Allain C.C., Poon L.S., Chan C.S.G., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin. Chem. 20:1974;470-475.
3. Awazu M., Parker R.E., Harvie B.R., Ichikawa I., Kon V. Down-regulation of endothelin-1 receptors by protein kinase C in streptozotocin diabetic rats. J. Cardiovasc. Pharmacol. 17(7):1991;S500-S502. Suppl.
4. Benigni A., Colosio V., Brena C., Bruzzi I., Bertani T., Remuzzi G. Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes. Diabetes. 47:1998;450-456.
5. Boulanger C., Luscher T.F. Release of endothelin from the porcine aorta. J. Clin. Invest. 85:1990;587-590.
6. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin. Chem. 19:1973;476-482.
7. A antagonist on neurovascular function in diabetic rats: interaction with the renin-angiotensin system. J. Pharmacol. Exp. Ther. 278:1996;1262-1268.
8. Cozza E.N., Vila M.C., Gomez-Sanchez C.E. Endothelin-1 receptors in C-6 cells: homologous down-regulation and modulation by protein kinase C. Mol. Cell. Endocrinol. 70:1990;155-164.
9. Epstein J.R., Sowers M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. Hypertension. 26:1995;869-879.
10. Frank H.J., Levin E.R., Hu R.M., Pedram A. Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells. Endocrinology. 133:1993;1092-1097.
11. 2, but not noradrenaline, of aorta from rats with streptozotocin-induced diabetes mellitus. Br. J. Pharmacol. 104:1991;928-932.
12. Guillon J.M., Thiry C., Roach A.G., Cavero I. Preferential reduction in vascular responses to endothelin-1 in rats with streptozotocin-induced diabetes. J. Cardiovasc. Pharmacol. 31(1):1998;S133-S137. Suppl.
13. Haak T., Jungmann E., Felber A., Hillman U., Usadel K.H. Increased plasma endothelin concentrations in diabetic patients with hypertension. Am. J. Hypertens. 5:1992;161-166.
14. Hattori Y., Kasai K., Nakamura T., Emoto T., Shimoda S.-I. Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Metabolism. 40:1991;165-169.
15. A receptor expression in rat aortic smooth muscle cells. Diabetes. 47:1998;937-944.
16. Hopfner R.L., Misurski D., Wilson T.W., McNeill J.R., Gopalakrishnan V. Insulin and vanadate restore decreased plasma endothelin concentrations and exaggerated vascular responses to normal in the streptozotocin diabetic rat. Diabetologia. 41:1998;1233-1240.
17. Lerman A., Edward B.S., Hallett J.W., Heublein D.M., Sandberg S.M., Burnett J.C. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N. Eng. J. Med. 325:1991;997-1001.
18. Lerman A., Edwards B.S., Hallett J.W., Heublein D.M., Sandberg S.M., Burnett J.C. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation. 88:1993;2923-2928.
19. Makino A., Kamata K. Elevated plasma endothelin-1 concentration in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Br. J. Pharmacol. 123:1998;1065-1072.
20. Malamitsi-Puchner A., Economou E., Katsouyanni K., Karachaliou F., Delis D., Bartsocas C.S. Endothelin 1-21 plasma concentrations in children and adolescents with insulin dependent diabetes mellitus. J. Paediatr. Endocrinol. Metab. 9:1996;463-468.
21. Morff R.J. Microvascular reactivity to norepinephrine at different arteriolar concentrations and durations of streptozocin-induced diabetes. Diabetes. 39:1990;354-360.
22. Oliver F.J., De La Rubia G., Feener E.P., Lee M.E., Loeken M.R., Shiba T., Quertermous T., King G.L. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J. Biol. Chem. 266:1991;23251-23256.
23. Pieper G. Review of alterations in endothelial nitric oxide production in diabetes. Hypertension. 31:1998;1047-1060.
24. Pieper G.M., Siebeneich W. Early augmentation of nitric oxide mediated endothelium dependent relaxation in streptozotocin diabetic rat aorta. Naunyn-Schmiedberg's Arch. Pharmacol. 358(suppl.1):1998;18-33. abstract.
25. Smulders R.A., Stehouwer C.D., Olthof C.G., Van Kamp G.J., Teerlink T., De Vries P.M., Donker A.J. Plasma endothelin concentrations and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin. Sci. (Colch). 87:1994;37-43.
26. Stevens E.J., Tomlinson D.R. Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes. Br. J. Pharmacol. 115:1995;373-379.
27. Takahashi K., Ghatei M.A., Lam H.C., O'Hallaran D.J., Bloom S.R. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. 33:1990;306-310.
28. Takahashi K., Suda K., Lam H.C., Ghatei M.A., Bloom S.R. Endothelin like immunoreactivity in rat models of diabetes mellitus. J. Endocrinol. 130:1991;123-127.
29. Takeda Y., Miyamori I., Yoneda T., Takeda R. Production of endothelin-1 from the mesenteric arteries of streptozotocin-induced diabetic rats. Life Sciences. 48:1991;2553-2556.
30. Vermes I., Spooren P.F., Kalsbeek-Batenburg E.M., Haanen C. In addition to von Willebrand factor and urinary albumin excretion, plasma endothelin is an indicator of endothelial dysfunction in diabetes mellitus. Diabetologia. 36:1993;472-473.
31. White R.E., Carrier G.O. Vascular contraction induced by activation of membrane calcium ion channels in streptozotocin diabetes. J. Pharmacol. Exp. Ther. 253:1990;1057-1062.
32. Wu S.-Q., Tang F. Impaired paracrine effect of endothelin-1 on vascular smooth muscle in streptozotocin diabetic rats. Cardiovasc. Res. 39:1998;651-656.
33. i elevation in the rat cardiomyocyte. Br. J. Pharmacol. 108:1993;6-8.
34. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
35. Yoshino G., Matsushita M., Maeda E., Naka Y., Nagata K., Morita M., Matsuba K., Kazumi T., Kasuga M. Effect of long-term insulin deficiency and insulin treatment on the composition of triglyceride rich lipoproteins and triglyceride turnover in rats. Atherosclerosis. 92:1992;243-250.